Semax/Selank Blend
Description
A research blend combining Semax (ACTH 4-10 analog with Pro-Gly-Pro extension) and Selank (tuftsin analog with Pro-Gly-Pro extension). Both are synthetic heptapeptide derivatives investigated for nootropic and anxiolytic properties. Research applications focus on cognitive function, neuroprotection, and neuroimmune modulation.
Research Summary
Semax and Selank are individually well-studied synthetic peptides developed at the Institute of Molecular Genetics (Russian Academy of Sciences). Semax has been investigated for cognitive enhancement and neuroprotection, while Selank shows anxiolytic and immunomodulatory properties in preclinical studies. The combination blend is used in nootropic research.
Mechanism of Action
Semax: Modulates BDNF and NGF expression through melanocortin receptor activation, enhancing neuroplasticity and neuronal survival. Selank: Enhances enkephalin stability and modulates IL-6 expression through tuftsin receptor signaling, affecting both immune and central nervous system function.
Known Research Compound Interactions
Based on published preclinical research literature
For laboratory research reference only. Not for human consumption. Interaction data derived from preclinical studies and receptor binding profiles. Always consult primary literature for specific research protocols.
Interaction assessments based on receptor binding affinity, signaling pathway analysis, and published preclinical data. For laboratory research use only. Not for human consumption.
Related Research
Price Comparison
For laboratory research use only. Not for human consumption.
Verified Sources for Semax/Selank Blend
Third-party COA verified vendors that stock Semax/Selank Blend. Check our discount codes page for exclusive offers.